Ovid Therapeutics Inc. (NASDAQ: OVID)
$1.04
+0.1010 ( +10.76% ) 622.1K
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.
Market Data
Open
$1.04
Previous close
$0.94
Volume
622.1K
Market cap
$73.78M
Day range
$0.93 - $1.05
52 week range
$0.68 - $4.14
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4/a | Other | 1 | Feb 14, 2024 |
8-k | 8K-related | 12 | Dec 06, 2023 |
4 | Insider transactions | 1 | Dec 06, 2023 |
10-q | Quarterly Reports | 68 | Nov 03, 2023 |
8-k | 8K-related | 14 | Nov 03, 2023 |
8-k | 8K-related | 13 | Oct 18, 2023 |
8-k | 8K-related | 119 | Oct 02, 2023 |
10-q | Quarterly Reports | 66 | Aug 04, 2023 |
8-k | 8K-related | 15 | Aug 04, 2023 |